Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib

Overview of attention for article published in Clinical Sarcoma Research, October 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#21 of 104)
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 1 patent

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 18 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS FOR TREATING SMARCB1 DEFICIENT CANCER OR PAZOPANIB RESISTANT CANCER

Application WO-2017203042-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.